Hualan Biological Engineering
002007.SZ
#3007
Rank
NZ$7.06 B
Marketcap
$3.86
Share price
-0.36%
Change (1 day)
-28.85%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): NZ$0.44 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are NZ$0.75 Billion. In 2023 the company made an earning of NZ$0.49 Billion, an increase over its 2022 earnings that were of NZ$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.44 B-10.22%
2023 NZ$0.49 B39.21%
2022 NZ$0.35 B-19.12%
2021 NZ$0.43 B-17.9%
2020 NZ$0.53 B37.11%
2019 NZ$0.38 B11.71%
2018 NZ$0.34 B50.84%
2017 NZ$0.23 B1.1%
2016 NZ$0.22 B23.49%
2015 NZ$0.18 B8.37%
2014 NZ$0.17 B10.83%
2013 NZ$0.15 B54.56%
2012 NZ$99.33 M-17.03%
2011 NZ$0.11 B-41.34%
2010 NZ$0.20 B6.15%
2009 NZ$0.19 B261.3%
2008 NZ$53.21 M85.75%
2007 NZ$28.64 M49.27%
2006 NZ$19.19 M56.98%
2005 NZ$12.22 M34.28%
2004 NZ$9.1 M